It was interesting to see that Apollo Endosurgery has sold the Lap-band device to Reshape Life Sciences and Reshape’s Duo balloon has gone in the other direction.
On the face of it, this seems a pretty smart deal. Apollo wants to pursue a strategy that is focused on endoluminal, non-surgical devices and procedures so the band no longer fits. We understand Apollo will mothball the Duo balloon so as to focus on their established BIB and Orbera devices. Reshape however see an opportunity to re-establish the band. It’ll be interesting to see how that develops as the sleeve is now the dominant procedure globally. They have a lot of ground to make up even though there remains a place in the market for the gastric band, especially among lower BMI patients who want a less invasive and reversible procedure.
It’ll be interesting to see how things develop in the months and years ahead. The logic appears sound, especially for Apollo, let’s see how it turns out.